Actavis CEO Brent Saunders and Allergan CEO David Pyott discuss the recent acquisition deal between the two companies with industry media. » Listen to the full interview here
Editorial Questions? Contact the Editorial Team. Click Here.
Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.
Like
Tweet
